Close Menu

Don't Wait Your Turn

One of DrugMonkey's readers relayed a bit of a situation. The reader is working on an R01 but a colleague who sits on a study section told the reader to "definitely wait two years so [the reader] can get things rolling before applying." DrugMonkey says that is nonsensical advice and that R01 funding is needed to get and keep a lab working and that waiting around isn't going to accomplish much.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

CNN reports that a US Food and Drug Administration document says Johnson & Johnson's SARS-CoV-2 vaccine meets the requirements to receive an Emergency Use Authorization.